| 000 | 01674 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516063633.0 | ||
| 264 | 0 | _c20120529 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1365-2559 | ||
| 024 | 7 |
_a10.1111/j.1365-2559.2011.04023.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuhamel, Laure A E | |
| 245 | 0 | 0 |
_aFrequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes. _h[electronic resource] |
| 260 |
_bHistopathology _cJan 2012 |
||
| 300 |
_a357-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Cycle Proteins |
| 650 | 0 | 4 |
_aGene Amplification _xgenetics |
| 650 | 0 | 4 |
_aGene Dosage _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-mdm2 _xgenetics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aYe, Hongtao | |
| 700 | 1 | _aHalai, Dina | |
| 700 | 1 | _aIdowu, Bernadine D | |
| 700 | 1 | _aPresneau, Nadège | |
| 700 | 1 | _aTirabosco, Roberto | |
| 700 | 1 | _aFlanagan, Adrienne M | |
| 773 | 0 |
_tHistopathology _gvol. 60 _gno. 2 _gp. 357-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2559.2011.04023.x _zAvailable from publisher's website |
| 999 |
_c21303321 _d21303321 |
||